Momaid clinical trial presented at the 2019 joint Annual Meeting of the American Urogynecologic Society (AUGS) and the International Urogynecological Association-(IUGA)

Dr. Peter Takacs, a Henry Clay Hofheimer II Professor of Obstetrics and Gynecology and the Division Director of Female Pelvic Medicine and Reconstructive Surgery (Urogynecology) at the Eastern Virginia Medical School, who is the lead researcher for Momaid has presented the randomized, double-blind clinical trial conducted at the University of Debrecen in Hungary. The mothers who took part in the study received vitamin preparations after giving birth. The therapeutic group was taking Momaid supplement for 6 weeks, while the control group received a standard postnatal vitamin. The results were very impressive for Momaid. Women randomized to the Momaid group were less likely to have weak vaginal squeeze pressure, presence of levator muscle injury, less anterior vaginal wall prolapse or bothersome bulge symptom and less likely to have wide genital hiatus. In summary, postpartum women receiving a specially formulated postpartum recovery supplement “Momaid vitamin” had improved recovery of the pelvic floor function after vaginal delivery.

“We are on a mission to help families be stronger through having healthier mothers who recover faster and better after childbirth,” commented Dr. Takacs “It is wonderful to see research confirming the benefits of Momaid.”